Medicare Enrolled

Dr. Helmi Khadra, M.D.

Surgical Oncology Physician · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
6550 FANNIN ST, Houston, TX 77030
3462385105
In practice since 2014 (12 years)
NPI: 1245657667 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Khadra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khadra? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Khadra

Dr. Helmi Khadra is a surgical oncology physician in Houston, TX, with 12 years in practice. Based on federal Medicare data, Dr. Khadra performed 334 Medicare services across 303 unique beneficiaries.

Between the years covered by Open Payments, Dr. Khadra received a total of $36,884 from 7 pharmaceutical and/or device companies across 51 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in surgical oncology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Khadra is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice▲ Top 22% volume in TX$ $36,884 industry payments

Medicare Practice Summary

Medicare Utilization ↗
334
Medicare services
Top 22% in TX for surgical oncology physician
303
Unique beneficiaries
$250
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~28 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
New patient office visit, complex (60-74 min)84$158$600
Removal or exploration of parathyroid glands54$669$4,641
Initial hospital admission, high complexity41$125$588
Hospital follow-up visit, moderate complexity36$54$211
Hospital follow-up visit, high complexity24$87$302
Removal of deep lymph nodes of neck17$178$2,690
Fine needle aspiration biopsy using ultrasound guidance, first growth16$101$655
Initial hospital admission, moderate complexity15$96$401
Office visit, established patient, complex (40-54 min)13$132$421
Office visit, established patient (30-39 min)12$88$314
Laparoscopic gallbladder removal11$489$3,707
Removal or re-exploration of parathyroid glands11$975$6,389
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$36,884
Total received (2021-2024)
Avg $9,221/year across 4 years
Top 12% in TX for surgical oncology physician
7
Companies
51
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$34,803 (94.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,081 (5.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$15,612
2023
$13,500
2022
$1,773
2021
$6,000

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Intuitive Surgical, Inc.
$20,964
INTUITIVE SURGICAL, INC.
$15,367
Bolton Medical Inc
$245
Baxter Healthcare
$212
Ethicon US, LLC
$47
Smith+Nephew, Inc.
$31
TELA Bio, Inc.
$20
Top 3 companies account for 99.2% of total payments
Associated products mentioned in payments ›
Da Vinci Surgical System · ECHELON ENDOPATH · Grafts · Harmonic · OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) · PERCLOT · STRAVIX PL · TISSEEL
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in surgical oncology physician and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $11,043 per 100 Medicare services performed
Looking for a surgical oncology physician in Houston?
Compare surgical oncology physicians in the Houston area by procedure volume, costs, and industry payment transparency.
Browse surgical oncology physicians nearby

Geographic Context

Surgical Oncology Physicians within 10 mi
60
Per 100K population
1.3
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Khadra is a clinical cardiology specialist, with above-average Medicare volume (top 22% in TX), and high industry engagement (speaking/promotional, top 12%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Khadra experienced with new patient office visit, complex (60-74 min)?
Based on Medicare claims data, Dr. Khadra performed 84 new patient office visit, complex (60-74 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khadra receive payments from pharmaceutical companies?
Yes. Dr. Khadra received a total of $36,884 from 7 companies across 51 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khadra's costs compare to other surgical oncology physicians in Houston?
Dr. Khadra's average Medicare payment per service is $250. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khadra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →